Tender detail

Open-house discount agreements for pegfilgrastim 2026-05

Summary

The participating health insurers are seeking discount agreements for the active ingredient pegfilgrastim with all suitable pharmaceutical companies under an open-house procedure with uniform terms and no exclusivity. The agreements may run for up to 24 months from 1 May 2026 and end no later than 30 April 2028; companies may join at any time during the contract period.

Reference number
e92cbe2b-ade7-4602-af43-c9031acda7a3
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-04-30
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.